Fundz
New|Fundz now works inside Claude2 min

Timing. Relevance. Relationships.

Fundz is the only platform that reads more than a dozen real‑time signals all day, every day, so you know about new funding, new executives and new contracts within minutes of them happening, not days or weeks later like the databases you’re used to. It then combines the signals on each company, scores every company against what you offer, and weaves in your own network, so you discover new accounts first and work existing ones better.

Each morning you get the ones worth your time right now: who to reach, why now, and who you already know there. Now it answers in Claude too: ask for today’s leads, then write the note in the same window.

Trusted by

OracleSnowflakeCloudflareLinkedInGoogleSalesforce
4.8/5 on G2· Since 2015

Merck KGaA to acquire Silence Therapeutics for $1.3B

PRIVATEOct 19, 2026

Acquiring Company

Merck KGaA Darmstadt Germany

Acquired Company

Silence Therapeutics plc

HesseGreater LondonManufacturingBiotechnologyHealth CareLife ScienceBiotechnologyTherapeutics

Description

Merck KGaA, Darmstadt, Germany has agreed to acquire Silence Therapeutics in an all-cash transaction valued at approximately $1.3 billion. This strategic acquisition enhances Merck's capabilities in biotechnology and strengthens its portfolio. The deal is expected to accelerate the development of Silence's innovative therapies. The acquisition agreement reflects Merck's commitment to advancing healthcare solutions.

Company Information

Company

Merck KGaA Darmstadt Germany

Location

Hesse, Germany

About

Merck KGaA is a leading science and technology company known for its innovative solutions in healthcare, life sciences, and performance materials. With a commitment to innovation and sustainability, it aims to improve the quality of life for patients globally. The company has a diverse portfolio and is focused on expanding its market presence. Merck KGaA is dedicated to strengthening its business sectors through strategic acquisitions.

Fundz sees it the moment Merck KGaA Darmstadt Germany makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Nuno
Senior decision-maker at this company
••••••••@••••••••

See Nuno's verified email →

Celine
Senior decision-maker at this company
••••••••@••••••••

See Celine's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Merck KGaA Darmstadt Germany's next move

Learn about Strategic plan

Frequently asked

Who acquired Silence Therapeutics plc?

Silence Therapeutics plc was acquired by Merck KGaA Darmstadt Germany, based in Hesse. The deal was reported on October 19, 2026. Merck KGaA is a leading science and technology company known for its innovative solutions in healthcare, life sciences, and performance materials. Merck KGaA Darmstadt Germany is privately held and operates in Manufacturing.

When did Merck KGaA Darmstadt Germany acquire Silence Therapeutics plc?

Merck KGaA Darmstadt Germany's acquisition of Silence Therapeutics plc was reported on October 19, 2026. Merck KGaA, Darmstadt, Germany has agreed to acquire Silence Therapeutics in an all-cash transaction valued at approximately $1.3 billion. This strategic acquisition enhances Merck's capabilities in biotechnology and strengthens its portfolio. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.

What does Silence Therapeutics plc do?

Silence Therapeutics plc is a biotechnology company specializing in the development of precision engineered medicines. Utilizing its proprietary siRNA technology, the company aims to create innovative therapies for various diseases. It is privately held, operating in Biotechnology, and is based in Greater London.

This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.